Healthy Overweight Volunteers

A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PHP-303 in Otherwise Healthy Overweight or Obese Subjects

Participants must meet the following criteria

  • Male or female volunteers 18-60 years of age

Study Visits

  • 1 in-house stay of 8 nights/9 days
  • 1 in-house stay of 6 nights/7 days
  • 7 follow up visits

 

Compensation

  • Receive up to $5,795

Cookie Policy

2019 © Altasciences. All Rights Reserved